Are peptides legal in France?
Sourced guide to the legal status of peptides in France, refreshed automatically from live research.
Overall Status: Gray Area
Short answer: Peptides are not a single legal category in France: pharmaceutical peptides such as semaglutide and somatropin (HGH) are legal only as prescription-only medicines regulated by ANSM, while non-approved "research peptides" like BPC-157 and TB-500 exist in a legal gray zone -- sold as research chemicals not authorized for human consumption, with no specific criminal ban but no lawful path to human use either.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides in France fall into two very different legal buckets, so there is no single blanket verdict. Approved peptide drugs (semaglutide/Ozempic, somatropin/growth hormone) are classified as medicines under the Code de la santé publique and can only be sold and used under prescription, with ANSM (Agence nationale de sécurité du médicament et des produits de santé) as the competent regulator. Unapproved "research chemical" peptides such as BPC-157 and TB-500 are not listed as narcotics or psychotropic substances, but they are also not authorized medicines, meaning vendors market them as not-for-human-use research products while genuine human therapeutic use sits outside any approved legal channel. ANSM has separately flagged growing off-label, weight-loss misuse of prescription GLP-1 peptide drugs and reinforced surveillance of that diversion.
Key Points
- Under Article L5111-1 of the Code de la santé publique, any substance presented as having curative or preventive properties, or intended for human physiological use, is legally defined as a 'médicament' (medicine) and falls under ANSM's regulatory authority in France. [1]
- ANSM maintains and periodically revises the consolidated French lists of substances classified as narcotics (stupéfiants) and psychotropic substances, and since a 2020 law the power to modify these lists sits with the ANSM director general rather than the health minister. [2]
- French Customs rules state that individuals may only personally import narcotic or psychotropic medicines if carried on their person, and the quantity must correspond to personal therapeutic use for the duration of a prescribed treatment. [3]
- ANSM and French national health insurance (Assurance Maladie) announced reinforced surveillance of Ozempic (semaglutide) in France after estimating that around 1% of use is diverted for non-diabetic weight-loss purposes rather than its approved type 2 diabetes indication. [4]
- Synthetic growth hormone (somatropine) products approved in France require strictly specialist prescribing, with initial hospital prescription renewed annually by pediatric, endocrinology, or metabolic-disease specialists. [5]
- Research peptides such as BPC-157 and TB-500 are sold in France as 'research chemicals' without any marketing authorization for human use, meaning there is no lawful retail channel for human consumption of these specific compounds. [6]
- TB-500 is listed among substances prohibited in competitive sport, so its use falls under anti-doping enforcement in France in addition to any medicines-law questions. [6]
- A 2026 Court of Justice of the European Union ruling in a case involving ANSM clarified the regulatory pathway for chemically synthesised peptides that reference originator biological medicines, affecting how generic/biosimilar peptide products can be authorized in France and the EU. [7]
Peptide-by-peptide status in France
| BPC-157 | BPC-157 has no marketing authorization as a medicine in France and is sold only as an unapproved 'research chemical' not intended for human use, so there is no legal retail or prescription pathway for human consumption of it. [6] |
|---|
| TB-500 | TB-500 is, like BPC-157, sold in France only as an unapproved research chemical without human-use authorization, and it is additionally listed as a prohibited substance in competitive sport under anti-doping rules. [6] |
|---|
| Semaglutide (GLP-1, e.g. Ozempic) | Semaglutide is a legal, ANSM-approved prescription medicine in France for type 2 diabetes, but ANSM has warned against and is increasing surveillance of its off-label prescription or use for weight loss outside that approved indication. [4] |
|---|
| Human Growth Hormone (somatropin) | Somatropin is a legal prescription-only medicine in France that can only be prescribed by specialists (pediatrics, endocrinology, or metabolic disease) with an annually renewed initial hospital prescription, so unprescribed personal use or acquisition falls outside the lawful framework. [5] |
|---|
Last researched: 2026-09-10
Frequently asked questions
No lawful prescription pathway exists for BPC-157 in France because it is not an ANSM-approved medicine; it is only available as an unauthorized 'research chemical' not intended for human consumption, which is a legal gray area rather than a regulated, prescribable product.
[6]
Yes, but only for approved prescription medicines carried personally in quantities matching a personal treatment prescription; French Customs specifically restricts personal import of narcotic or psychotropic medicines to what a traveler carries on themselves for the duration of prescribed therapy.
[3]
ANSM has reinforced surveillance specifically because semaglutide is approved in France only for type 2 diabetes, and the agency has flagged off-label weight-loss prescribing as diversion/misuse rather than an approved telehealth use case.
[4]
No specific customs enforcement statistics for research peptides were found in available sources; French customs rules generally restrict personal import of unauthorized medicinal substances, and unapproved research-chemical peptides fall outside the personal-medicine import allowance described by French Customs for prescribed narcotic/psychotropic drugs.
No, in France somatropin (synthetic HGH) is a prescription-only medicine that can legally only be prescribed by specialists in pediatrics, endocrinology, or metabolic diseases with hospital-initiated, annually renewed prescriptions, so using it without such a diagnosed medical need and prescription falls outside the lawful framework.
[5]